MAO Meiling,LU Jianqi,XIE Liyu,et al.Potential Mechanism of Action of Qiangxin Decoction (强心汤) for Chronic Heart Failure Based on Network Pharmacology and Molecular Docking[J].Journal of Traditional Chinese Medicine,2023,64(20):2132-2137.
MAO Meiling,LU Jianqi,XIE Liyu,et al.Potential Mechanism of Action of Qiangxin Decoction (强心汤) for Chronic Heart Failure Based on Network Pharmacology and Molecular Docking[J].Journal of Traditional Chinese Medicine,2023,64(20):2132-2137.DOI: 10.13288/j.11-2166/r.2023.20.014.
Potential Mechanism of Action of Qiangxin Decoction (强心汤) for Chronic Heart Failure Based on Network Pharmacology and Molecular Docking
To reveal the targets and molecular mechanisms of the action of
Qiangxin Decoction
(强心汤) for the treatment of chronic heart failure based on the combination of network pharmacology and molecular docking.
Methods
2
The active ingredients of
Qiangxin Decoction
were retrieved from TCMSP database, and the targets of chronic heart failure were screened by searching GeneCards, OMIM, TTD, PharmGkb, and DrugBank databases, and the intersections were taken to obtain the intersecting targets of
Qiangxin Decoction
for the treatment of chronic heart failure. STRING platform was used to construct the protein-protein interaction network (PPI), Cytoscape 3.8.0 software was used to calculate the network topology to screen the core targets, and R 4.2.3 was used to construct the “active ingredient-target” network by analyzing the GO enrichment analysis and KEGG pathway enrichment analysis. AutoDock 1.5.7 was used for molecular docking to predict the binding performance of active ingredients and core targets.
Results
2
Seventy-five intersecting targets were identified for the treatment of chronic heart failure with
Qiangxin Decoction
, among which the core targets were estrogen receptor 1 (ESR1, degree value=7), nuclear receptor coactivator 1 (NCOA1, degree value=8), glucocorticoid receptor (NR3C1, degree value=7), and nuclear receptor coactivator 2 (NCOA2, degree value=7). GO enrichment analysis showed that the top 3 items with the smallest
P
value in molecular function were G protein-coupled amine receptor activity, postsynaptic neurotransmitter receptor activity, and neurotransmitter receptor activity (
P
<0.01); the top 3 items with the smallest
P
value in biological process were adenylyl cyclase-activated adrenergic receptor signaling pathway, adrenergic receptor signaling pathway, and adenylyl cyclase-regulated G protein-coupled receptor signaling pathway (
P
<0.01); the top 3 items with the smallest P values in cellular composition were components of the postsynaptic membrane, synaptic membrane, and presynaptic membrane (
P
<0.01). KEGG enrichment analysis showed that the top 5 key signaling pathways were neuroactive ligand-receptor interactions, calcium signaling pathway, dopaminergic synapses, cocaine addiction, and cyclic guanosine monophosphate-protein kinase G (cGMP-PKG) signaling pathway. The molecular docking results showed that lignans and isoflavones had lower binding energies and more structural stability with the four core targets (ESR1, NCOA1, NR3C1, NCOA2).
Conclusion
2
The treatment of chronic heart failure by
Qiangxin Decoction
was associated with neuroactive ligand-receptor interactions, calcium signaling pathway, dopaminergic synapses, chemoattractant-receptor activation, cGMP-PKG signaling pathway, lipids and atherosclerosis, and cAMP signaling pathway, and lignans and isoflavones may be the core active compounds in its treatment of chronic heart failure.
关键词
Keywords
references
METRA M , TOMASONI D , ADAMO M , et al . Worsening of chronic heart failure: definition, epidemiology, ma-nagement and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology [J]. Eur J Heart Fail , 2023 , 25 ( 6 ): 776 - 791 .
FILIPPO C . Epidemiology and treatment of acute and chronic heart failure [J]. Eur Heart J , 2023 , 44 ( 5 ): 329 - 332 .
BARABÁSI AL , GULBAHCE N , LOSCALZO J . Network medicine: a network-based approach to human disease [J]. Nat Rev Genet , 2011 , 12 ( 1 ): 56 - 68 .
NAQVI AAT , MOHAMMAD T , HASAN GM , et al . Advancements in docking and molecular dynamics simulations towards ligand-receptor interactions and structure-function relationships [J]. Curr Top Med Chem , 2018 , 18 ( 20 ): 1755 - 1768 .
SAIKIA S , BORDOLOI M . Molecular docking: challenges, advances and its use in drug discovery perspective .[J]. Curr Drug Targets , 2019 , 20 ( 5 ): 501 - 521 .
CHEN G , SEUKEP AJ , GUO M . Recent advances in molecular docking for the research and discovery of potential marine drugs .[J]. Mar Drugs , 2020 , 18 ( 11 ): 545 - 545 .
Mechanism of Yishen Qubi Tongluo Formula (益肾祛痹通络方) in the Treatment of Rheumatoid Arthritis:Based on Network Pharmacology,Molecular Docking and Experimental Verification
Exploring the Mechanism of Action of Qizhu Kang'ai Formula (芪术抗癌方) for the Treatment of Colorectal Cancer based on Network Pharmacology and Experimental Validation
The Mechanism of Yaotongning Capsule (腰痛宁胶囊) in Treating Lumbar Disc Herniation:based on Network Pharmacology and Molecular Docking
A Network Pharmacology-based Approach to Explore the Mechanism of Xuanbai Chengqi Decoction (宣白承气汤) Against Acute Respiratory Distress Syndrome
The Mechanism of Qiyin Sanliangsan(芪银三两三) in the Treatment of Idiopathic Pulmonary Fibrosis based on Network Pharmacology and Molecular Docking
Related Author
XU Liuping
YANG Canyu
LU Ying
MO Lisha
CHI Qiang
XIA Yuan
LIU Shuijuan
QIU Mingliang
Related Institution
Affiliated Hospital of Jiangxi University of Chinese Medicine
Clinical Medical College of Jiangxi University of Chinese Medicine
School of Chinese Medicine, Nanjing University of Chinese Medicine
School of Pharmacy, Nanjing University of Chinese Medicine